Culturing Human Mesenchymal Stem Cells on Bioceramics for Hard Tissue Regeneration (Validation of In Vitro Bone Matrix Formed on Ceramics for Clinical Application)

Abstract:

Article Preview

Alumina ceramics have excellent mechanical and biocompatible properties, but are bioinert and hence have no bone-bonding properties. We took a tissue engineering approach in an attempt to modify the ceramic surface and so provide an osteogenic/osteoconductive milieu. We used fresh human bone marrow cells obtained from the iliac crest by needle aspiration for culture expansion of mesenchymal stem cells (MSC) followed by in vitro osteogenic differentiation on both tissue culture polystyrene (TCPS) and alumina ceramics. We have succeeded in expanding the number of MSC from all 35 cases and compared the differentiation capability of selected MSC on alumina ceramics to that on TCPS. The cells on both substrata showed extensive alkaline phosphatase staining and mineralization as evidenced by calcein uptake. Biochemical analyses revealed high levels of alkaline phosphatase activity, osteocalcin expression, and calcium content. These data indicate that an alumina ceramic surface can support a differentiation cascade of MSC resulting in osteoblastic phenotype expression of the cells. Based on these results, we have performed clinical applications of tissue engineered total joint replacements for osteoarthritic patients.

Info:

Periodical:

Key Engineering Materials (Volumes 284-286)

Main Theme:

Edited by:

Panjian Li, Kai Zhang and Clifford W. Colwell, Jr.

Pages:

603-606

DOI:

10.4028/www.scientific.net/KEM.284-286.603

Citation:

H. Ohgushi et al., "Culturing Human Mesenchymal Stem Cells on Bioceramics for Hard Tissue Regeneration (Validation of In Vitro Bone Matrix Formed on Ceramics for Clinical Application) ", Key Engineering Materials, Vols. 284-286, pp. 603-606, 2005

Online since:

April 2005

Export:

Price:

$35.00

[1] Caplan AI, Clin Plast Surg. 1994 Jul; 21(3): 429-35.

[2] Ohgushi H, Caplan AI. J Biomed Mat Res 1999; 48: 913-27.

[3] Ohgushi H, Miyake J, Tateishi T. Novartis Found Symp. 2003; 249: 118-27.

[4] Ohgushi H, Dohi Y, Katuda T, Tamai S, Tabata S, Suwa Y. J Biomed Mat Res 1996; 32: 333-40.

DOI: 10.1002/(sici)1097-4636(199611)32:3<333::aid-jbm5>3.0.co;2-t

[5] Kitamura S, Ohgushi H, Hirose M, Funaoka H, Takakura Y, Ito H. Artif Organs. 2004 Jan; 28(1): 72-82.

[6] Kotobuki N, Hirose M, Takakura Y, Ohgushi H. Artif Organs 2004; 28: 33-39.

[7] Ohgushi H, Dohi Y, Yoshikawa T, Tamai S, Tabata S, Okunaga K, Shibuya T. J Biomed Mat Res 1996; 32: 341-8.

[8] Maniatopoulos C, Sodek J, Melcher AH. Cell Tissue Res 1988; 254: 317-30.

[9] Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. J Cell Biochem 1997; 64: 295-31.

[10] Uchimura E, Machida H, Kotobuki N, Kihara T, Kitamura S, Ikeuchi M, Hirose M, Miyake J, Ohgushi H. Calcif Tissue Int 2003 73(6): 575-83.

DOI: 10.1007/s00223-002-1052-3

In order to see related information, you need to Login.